Free Trial

Intuitive Surgical (NASDAQ:ISRG) Shares Unloaded Rep. Lisa C. McClain

Intuitive Surgical logo with Medical background

Key Points

  • Representative Lisa C. McClain sold shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) valued between $1,001 and $15,000 in a transaction on July 16th.
  • Intuitive Surgical's stock increased by 0.7% to $480.26, with a market cap of $172.16 billion and a PE ratio of 66.98.
  • Intuitive Surgical reported earnings of $2.19 per share for the last quarter, exceeding expectations and indicating a revenue growth of 21.4% compared to the previous year.
  • Need better tools to track Intuitive Surgical? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Representative Lisa C. McClain (R-Michigan) recently sold shares of Intuitive Surgical, Inc. NASDAQ: ISRG. In a filing disclosed on August 13th, the Representative disclosed that they had sold between $1,001 and $15,000 in Intuitive Surgical stock on July 16th. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.

Representative Lisa C. McClain also recently made the following trade(s):

  • Sold $1,001 - $15,000 in shares of Autoliv NYSE: ALV on 8/4/2025.
  • Sold $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 8/4/2025.
  • Sold $1,001 - $15,000 in shares of Applied Materials NASDAQ: AMAT on 8/4/2025.
  • Sold $1,001 - $15,000 in shares of Arthur J. Gallagher & Co. NYSE: AJG on 8/4/2025.
  • Sold $1,001 - $15,000 in shares of SAP NYSE: SAP on 7/22/2025.
  • Purchased $1,001 - $15,000 in shares of XPO NYSE: XPO on 7/22/2025.
  • Purchased $1,001 - $15,000 in shares of Lithia Motors NYSE: LAD on 7/22/2025.
  • Sold $1,001 - $15,000 in shares of Sanofi NASDAQ: SNY on 7/22/2025.
  • Sold $1,001 - $15,000 in shares of Waters NYSE: WAT on 7/22/2025.
  • Purchased $1,001 - $15,000 in shares of Group 1 Automotive NYSE: GPI on 7/22/2025.

Intuitive Surgical Price Performance

Shares of ISRG stock traded up $0.7660 on Wednesday, hitting $479.9660. The company's stock had a trading volume of 175,979 shares, compared to its average volume of 1,980,961. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The firm's fifty day moving average price is $506.84 and its 200-day moving average price is $523.82. The stock has a market capitalization of $172.06 billion, a price-to-earnings ratio of 67.11, a P/E/G ratio of 5.04 and a beta of 1.59.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. During the same quarter in the previous year, the business earned $1.78 EPS. Intuitive Surgical's quarterly revenue was up 21.4% compared to the same quarter last year. Analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. Norges Bank acquired a new position in Intuitive Surgical in the 2nd quarter valued at approximately $2,569,260,000. Nuveen LLC acquired a new position in Intuitive Surgical in the 1st quarter valued at approximately $1,715,899,000. GAMMA Investing LLC raised its holdings in Intuitive Surgical by 54,010.7% in the 1st quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock valued at $14,999,630,000 after acquiring an additional 3,022,979 shares in the last quarter. Capital Research Global Investors raised its stake in shares of Intuitive Surgical by 25.5% in the fourth quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock valued at $1,764,904,000 after purchasing an additional 687,906 shares in the last quarter. Finally, Vanguard Group Inc. raised its stake in shares of Intuitive Surgical by 2.1% in the second quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider's stock valued at $18,115,025,000 after purchasing an additional 670,302 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Insider Activity at Intuitive Surgical

In other news, EVP Myriam Curet sold 4,500 shares of the stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the transaction, the executive vice president owned 353 shares in the company, valued at approximately $173,845.44. This represents a 92.73% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Mark Brosius sold 216 shares of the stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the transaction, the senior vice president directly owned 907 shares of the company's stock, valued at $510,740.77. This trade represents a 19.23% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 15,839 shares of company stock worth $7,896,972. 0.70% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

ISRG has been the subject of a number of analyst reports. Royal Bank Of Canada reaffirmed an "outperform" rating and issued a $615.00 price target on shares of Intuitive Surgical in a research report on Tuesday. Wells Fargo & Company boosted their target price on Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a report on Wednesday, July 23rd. Wall Street Zen upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Saturday, July 26th. UBS Group boosted their price objective on shares of Intuitive Surgical from $547.00 to $585.00 and gave the stock a "neutral" rating in a research note on Wednesday, July 23rd. Finally, Truist Financial boosted their target price on shares of Intuitive Surgical from $590.00 to $600.00 and gave the stock a "buy" rating in a research report on Wednesday, July 23rd. Thirteen investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Intuitive Surgical presently has an average rating of "Moderate Buy" and an average target price of $595.95.

Get Our Latest Analysis on ISRG

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election. Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

Intuitive Surgical Company Profile

(Get Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Articles

Should You Invest $1,000 in Intuitive Surgical Right Now?

Before you consider Intuitive Surgical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.

While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Follow the Money: 5 Stocks Institutions Are Buying NOW
Strong Earnings? Market Says NVIDIA-Level Growth or Be Forgotten
Palantir’s Soaring Valuation—Justified or Overhyped?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines